Skip to main content

Table 2 Gene targets of the most common described human cancer-associated miRNAs

From: Novel classes of non-coding RNAs and cancer

MiRNA

Associated cancers

In vitro confirmed gene targets

MiR-21

CRC, PC, RCC, GBM, BrC, NSCLC, BCL, PTC, HCC, HNSCC, ESCC, GC, CML, CCC, MM, OC, M, LC, PDA

PDCD4, TIMP3, RhoB, Spry1, PTEN, TM1, CDK2AP1, ANP32A, SMARCA4, ANKRD46, THRB, Cdc25A, BMPRRII, LRRFIP1, BTG2, MARCKS, TPM1

MiR-155

NSCLC, SCLC, HCC, BrC, M, CCC, HL, PDA, RCC, GBM, PTC, CML, CRC, SPA, AML, NPC, CLL

FOXO3A, SOX6, SATB1, SKI, Wee1, SOCS1, SHIP1, S/EBPβ, IFN-γRα, AGTR1, FGF7, ZNF537, ZIC3, IKBKE, RhoA, BACH1, ZIC3, HIVEP2, CEBPB, ZNF652, ARID2, SMAD5, TP53INP1

MiR-145

BrC, CRC, ESCC, NSCLC, PC, BCL, OC, GC, BlC, NPC, HCC

c-Myc, ERK5, FSCN1, SMAD2/3, IGF-1R, FLI1, DFF45, mucin 1, MYO6, CBFB, PPP3CA, CLINT1, ICP4, RTKN

MiR-221

BrC, PC, CRC, M, GBM, ALL, HCC, PTC, PDA, GC, CML, NSCLC, AML, OC

DVL2, KIT, CDKN1B, Bmf, p27, HOXB5, CDKN1C/p57, CDKN1B/p27, MMP1, SOD2, TIMP3, Dicer1, ERα, ARHI, PUMA, p27Kip1, p57

MiR-222

  

Let-7a

M, HL, nHL, CRC, SLC, NSCLC, GC, HNSCC, ESCC, OC, CLL, HCC

PRDM-1, STAT3, Caspase-3, Integrin β3, PRDM1/blimp-1

MiR-16

LC, OC, NPC, GC, PC, BrC, HCC, MM, CLL, HL

VEGFR2, FGFR1, Zyxin, Cyclin E1, Bmi-1, BRCA-1, BCL2

MiR-200

BrC, PDA, GC, HNSCC, M, OC, PC

FN1, MSN, NTRK2, LEPR, ARHGAP19, ZEB1/2, Flt1/VEGFR1, FAP-1, FOG2, ERRFI-1

MiR-205

M, BrC, PC, ESCC, HNSCC

Runx2, E2F1, ErbB3, Zeb1

MiR-31

PTC, CRC, BrC, LC, GC, HCC

LATS2, WAVE3, SATB2, ITGA5, RDX, RhoA, FIH

MiR-126

CRC, GC, BrC, SCLC, AML, NSCLC, HCC

SLC7A5, SOX2, PLAC1, VEGFA, PIK3R2, Crk, EGFL7, p85beta

MiR-210

PDA, RCC, BrC, PC, GBM, NSCLC, OC, GC, HNSCC

FGFRL1, SDHD, MNT

MiR-9

GBM, PC, nHL, EC, OC

CAMTA1, PDGFR-β, CDX2, PRDM-1, E-cadherin, NF-kappaB1

MiR-141

PC, EC, CRC, HNSCC, LC, BrC, ESCC, OC, RCC

SIP1, YAP1

MiR-122

HCC, RCC

Bcl-w, ADAM17

  1. CRC colorectal cancer, PC prostate cancer, RCC renal cell carcinoma, GBM glioblastoma multiforme, BrC breast cancer, LC lung cancer, NSCLC non-small cell lung cancer, SCLC small cell lung cancer, BCL B-cell lymphoma, PTC papillary thyroid carcinoma, HCC hepatocellular carcinoma, HNSCC head and neck squamous cell carcinoma, ESCC esophagus squamous cell carcinoma, GC gastric cancer, CLL chronic lymphocytic leukemia, CML chronic myelogenous leukemia, ALL acute lymphocytic leukemia, AML acute myeloid leukemia, CCC cervical cell carcinoma, MM multiple myeloma, OC ovarian cancer, M melanoma, LC laryngeal carcinoma, PDA pancreatic ductal adenocarcinoma, HL Hodgkin lymphoma, nHL Non-Hodgkin lymphoma, SPA sporadic pituitary adenomas, NPC nasopharyngeal carcinoma, BlC bladder cancer, EC endometrial cancer.